NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Precision Imaging to Evaluate Kaposi Sarcoma

RecruitingNA

Sponsor: Washington University School of Medicine

Conditions: Kaposi Sarcoma

Interventions: SkinScan3D

Countries: Kenya, Uganda

AIMS 2 \& 3: In this study the investigators seek to formally compare reproducibility and accuracy of KS lesion size measurements between SkinScan3D and the current standard of care manual measurement method. The investigators will then test the SS3D device on 100 patients in a variety of real-world practice locations to determine whether the device will be usable, acceptable, appropriate, and feasible in routine care settings.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria - Aim 2 (Patients):

* Adults age ≥18 years old
* Histopathology-confirmed Kaposi Sarcoma
* At least 3 skin lesions
* Capable of informed consent
* On treatment for Kaposi Sarcoma

Exclusion Criteria - Aim 2 (Patients):

* Patients not initiating Kaposi Sarcoma treatment
* Very ill patients requiring hospitalization

Inclusion Criteria - Aim 3 (Patients):

* Adults age ≥18 years old
* Histopathology-confirmed Kaposi Sarcoma
* Capable of informed consent
* Initiating treatment for Kaposi Sarcoma

Exclusion Criteria - Aim 3 (Patients):

* Patients with Kaposi Sarcoma that participated in Aim 1 or Aim 2
* Prior or ongoing Kaposi Sarcoma treatment

Locations (2)

Kisumu, Kenya
Kampala, Uganda